Bill
SB 334
The bill repeals North Carolina’s drug tax (Article 2D), removing the excise tax on certain controlled substances.
Status and basic info
- Bill number: SB 334
- Short title: Repeal the NC Drug Tax
- Sponsors: Senators Mayfield and Meyer
- Introduced: February 12, 2025
- Subject classification: Controlled substances; public; taxation; excise taxes
- Current status (as provided): Passed first reading (Senate); referred to Rules and Operations of the Senate.
Purpose and intent
- The bill would remove North Carolina’s statutory “drug tax” by repealing Article 2D of Subchapter I of Chapter 105 of the General Statutes. Its stated intent is to eliminate that statutory excise regime.
Key provisions
- Section 1: Repeals Article 2D of Subchapter I of Chapter 105 of the General Statutes (the provisions that currently establish and govern the NC drug tax).
- Section 2: Savings clause — the repeal does not retroactively affect rights or liabilities that arose under the repealed statute prior to the effective date; it preserves any refund or credit rights that accrued before repeal.
- Section 3: Effective date — the act becomes effective when it becomes law (i.e., immediate effect upon enactment).
Who would be affected
- Entities/individuals previously subject to Article 2D: taxpayers, distributors, or other persons whose activities were taxed under that Article (specifics depend on the existing statutory definitions and coverage in Article 2D).
- State and local government finance: any fund(s) or programs that currently receive revenue from the Article 2D tax would lose that revenue stream if the repeal is enacted.
- Administrative/enforcement bodies: the Department of Revenue and any agencies that administered or enforced the Article 2D requirements would see an administrative change in responsibilities.
Potential impacts and considerations
- Revenue: repeal would reduce whatever excise revenue the drug tax currently generated. The magnitude depends on current collections; a fiscal note (not included here) is needed to quantify the impact.
- Administration: repeal would eliminate compliance obligations and enforcement activities tied solely to Article 2D, potentially reducing administrative costs but also eliminating a statutory mechanism for penalizing or taxing certain conduct.
- Legal/fiscal transition: the bill’s savings clause preserves existing liabilities and refund rights, limiting retroactive disruption.
- Policy implications: repeal may raise questions about alternative funding for programs (if Article 2D proceeds currently fund specific programs) and about broader strategies addressing controlled-substance distribution and public health.
Procedural/timeline notes
- Introduced Feb 12, 2025; passed first reading in the Senate and referred to Rules and Operations of the Senate. Next steps (typical): committee consideration, floor votes in both chambers, enrollment, and governor’s signature. Because the bill takes effect upon becoming law, any enactment would be immediate.
Recommendation / where to look next
- To assess exact legal and fiscal effects, review: (1) the current text of Article 2D (Chapter 105, Subchapter I) to determine taxable events, rates, exemptions, and recipients of revenue; and (2) any fiscal analyses or revenue estimates produced by the legislature or the Office of State Budget and Management. These documents will show who has been paying the tax and how much revenue would be lost or shifted.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
